Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Mar;58(1):128-138.
doi: 10.20471/acc.2019.58.01.17.

TGF-BETA IN THE NATURAL HISTORY OF PROSTATE CANCER

Affiliations
Review

TGF-BETA IN THE NATURAL HISTORY OF PROSTATE CANCER

Jamal Ahel et al. Acta Clin Croat. 2019 Mar.

Abstract

All transforming growth factors beta (TGFß) are cytokines that regulate several cellular functions such as cell growth, differentiation and motility. They may also have a role in immunosuppression. Their role is important for normal prostate development. TGFß is active in the regulation of balance between epithelial cell proliferation and apoptosis through stromal epithelia via the androgen receptor action. TGFß protects and maintains prostate stem cells, an important population necessary for prostate tissue regeneration. However, TGFß is shown to have a contrasting role in prostate tumor genesis. In the early stages of tumor development, TGFß acts as a tumor suppressor, whereas in the later stages, TGFß becomes a tumor promoter by inducing proliferation, invasion and metastasis. In this review, we outline complex interactions that TGFß-mediated signaling has on prostate tumor genesis, focusing on the role of these interactions during the course of prostate cancer and, in particular, during disease progression.

Keywords: Disease progression; Prostatic neoplasms; Receptors, androgen; Stem cells; Transforming growth factor beta.

PubMed Disclaimer

Similar articles

Cited by

References

    1. American Cancer Society. Cancer Facts & Figures 2009. Atlanta: American Cancer Society, 2009.
    1. Kelly RW, Critchley HO. Immunomodulation by human seminal plasma: a benefit for spermatozoon and pathogen? Hum Reprod. 1997;12:2200–7. 10.1093/oxfordjournals.humrep.a019559 - DOI - PubMed
    1. Robertson SA, Ingman WV, O’Leary S, et al. Transforming growth factor beta – a mediator of immune deviation in seminal plasma. J Reprod Immunol. 2002;57:109–28. - PubMed
    1. Issacs JT. In benign prostate hyperplasia. Rodgers CH, et al., eds. 1985;Vol 2:85-94.
    1. Russell PJ, Bennett S, Stricker P. Growth factor involvement in progression of prostate cancer. Clin Chem. 1998;44:705–23. - PubMed

MeSH terms

Substances

LinkOut - more resources